retatrutide type 2 diabetes phase 2 trial results 2024 is gaining attention in metabolic research for its triple agonist activity on GIP, GLP-1, and glucagon receptors. In this carousel, we summarize recent clinical study findings related to weight management, Efficacy and safety of retatrutide,

A provider who runs comprehensive bloodwork, including thyroid panel, cortisol, insulin, and HbA1c, can identify whether a treatable condition is sabotaging your results

A luminescence-based output would enable non-invasive, real-time monitoring in living organisms

That uncertainty drives people to search for answers at 2 a.m., scrolling through forums, comparing notes with strangers, and questioning whether their medication is even working

Qing S, Yuan S, Yun C, Hui H, Mao P, Wen F, Ding Y, Liu Q

Once-weekly exenatide versus once- or twice-daily insulin detemir: randomized, open-label, clinical trial of efficacy and safety in patients with type 2 diabetes treated with metformin alone or in combination with sulfonylureas

The pharmacokinetic properties of GLP-1 medications vary considerably